The New York Times reports that biohackers are also concerned about the potential harms of DIY genetic engineering.
The Genome Project–write leaders propose the development of virus-resistant cells, according to Science.
The award expands an existing collaboration between the firms for automated organism design.
ExxonMobil and Synthetic Genomics are moving forward with their exploration of algae-based biofuels, the San Diego Union-Tribune reports.
In Science this week: genetic overlap between five psychiatric disorders, and more.
The company, which was founded in 2016, said it would use the funding to further develop its core gene synthesis platform.
DNA Script has acquired an exclusive license to a novel DNA building block for use in enzymatic DNA synthesis.
GenScript believes that CustomArray's oligonucleotide synthesis and microarray manufacturing technology will enable it to better serve its customers.
The Boston-based synthetic biology company will use the proceeds to grow Bioworks3, its new organism foundry, and to expand into new markets.
In Nature this week: genomic analysis of malaria-carrying mosquitos reveals genetic diversity, and more.
At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.
The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.
Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.
In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.